Destiny Wealth Partners, LLC Novo Nordisk A S Transaction History

Destiny Wealth Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	BUY	$102.55 - $135.33 $4,717 - $6,225	46 Added 26.14%	222 $0
Q2 2022 Jul 15, 2022	BUY	$103.24 - $121.81 $4,439 - $5,237	43 Added 32.33%	176 $20,000
Q3 2021 Oct 28, 2021	BUY	$84.42 - $106.62 $11,227 - $14,180	133 New	133 $13,000
Q2 2021 Jul 27, 2021	SELL	$67.66 - $84.76 $8,998 - $11,273	-133 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$63.89 - $73.8 $8,497 - $9,815	133 New	133 $9,000

1,955

318M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $193B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Destiny Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Destiny Wealth Partners, LLC with notifications on news.